🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, controlled, open-label Phase III clinica...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-06
Trial ID
NCT06792253
About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-07-01
Trial ID
NCT00712582
RATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells ...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1999-11
Trial ID
NCT00005631
Treatments Being Tested
The primary objectives of this study are to evaluate safety, tolerability, ...
Status
Withdrawn
Location
Centre Hospitalier Régional Universitaire de Lille
Start Date
2019-06
Trial ID
NCT03349346
Treatments Being Tested
This phase II trial studies the effect of ascorbic acid and combination che...
Status
Recruiting
Location
Mayo Clinic Health Systems-Mankato
Start Date
2018-03-23
Trial ID
NCT03418038
Treatments Being Tested
To evaluate the tolerability,feasibility, and efficacy of combining acalabr...
Status
Unknown
Location
Swedish Cancer Institute
Start Date
2019-08-16
Trial ID
NCT03736616
Incorporation of rituximab to conventional chemotherapy (R-CHOP) has revolu...
Status
Completed
Location
Singapore General Hospital
Start Date
2010-11
Trial ID
NCT01226849
Treatments Being Tested
This study utilizes a prospective, multicenter, randomized two-arm design t...
Status
Recruiting
Location
Dongyang People's Hospital
Start Date
2024-08-01
Trial ID
NCT06520163
Treatments Being Tested
This phase II/III trial tests adding glofitamab to standard of care chemoim...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-30
Trial ID
NCT07724457
Treatments Being Tested
This phase I/II trial is studying the side effects and best dose of vorinos...
Status
Completed
Location
Puget Sound Oncology Consortium
Start Date
2007-12
Trial ID
NCT00601718